Roles of SIRTI and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma a375-s2 cell death
Roles of SIRTI and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma a375-s2 cell death
复制标题
DOI:
10.1254/jphs.fpj04055x
复制
发表时间:
2005-04-01
影响因子:
3.5
通讯作者:
Ikejima, T
中科院分区:
文献类型:
--
作者:
Wang, C;Wang, MW;Ikejima, T
We previously demonstrated that evodimine isolated from Evodia rutaecarpa (Goshuyu in Japan) induced apoptosis in human malignant melanoma A375-S2 cells within 24 h. In this study, TUNEL assay also indicated that one cause of A375-S2 cell death induced by evodiamine was apoptosis. After treatment with evodiamine for the indicated time periods, antiapoptotic protein SIRT1 expression was decreased; p53 expression and its phosphorylation were both enhanced, whereas transient induction of downstream p21 was not enough to promote cell cycle arrest. Inhibition of the phosphoinositide 3-OH kinase (PI3-K)/protein kinase C (PKC) survival pathway as well as subsequent inhibition of the ERK cascade might contribute to evodiamine-induced cell death. In addition, p53 activation in response to evodiamine administration was correlated with the activation of the PI3-K/PKC pro-apoptotic pathway, but did not require ERK participation. The inhibition of the PI3-K/PKC survival pathway might be responsible for SIRT1 inactivation and increased Bax/Bcl-2 expression ratio in evodiamine-induced cell death.